Journal Article Review Epublish 32 citations
PubMed: 34835476 DOI: 10.3390/microorganisms9112351
Impact of -Related Metabolic Syndrome Parameters on Arterial Hypertension.
Microorganisms 9(11)
Authors: Jannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, Georgia Deretzi, Elisabeth Vardaka, Elpidoforos S Soteriades, Maria Tzitiridou-Chatzopoulou, Paraskevas Gkolfakis, Kyriaki Karafyllidou, Michael Doulberis
Affiliations
- Second Medical Clinic, School of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
- Department of Gastroenterology, University Hospital of Larisa, 41110 Larisa, Greece.
- First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- Multiple Sclerosis Unit, Department of Neurology, Papageorgiou General Hospital, 56403 Thessaloniki, Greece.
- Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, 57400 Thessaloniki, Greece.
- Healthcare Management Program, School of Economics and Management, Open University of Cyprus, Nicosia 2252, Cyprus.
- Department of Environmental Health, Environmental and Occupational Medicine and Epidemiology (EOME), Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
- School of Healthcare Sciences, Midwifery Department, University of West Macedonia, Koila, 50100 Kozani, Greece.
- Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme University Hospital, 1070 Brussels, Belgium.
- Department of Medical Oncology, Institut Jules Bordet, 1000 Brussels, Belgium.
- Department of Pediatrics, University Children's Hospital of Zurich, 8032 Zurich, Switzerland.
- Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau, 5001 Aarau, Switzerland.
Abstract
Arterial hypertension is a risk factor for several pathologies, mainly including cardio-cerebrovascular diseases, which rank as leading causes of morbidity and mortality worldwide. Arterial hypertension also constitutes a fundamental component of the metabolic syndrome. infection is one of the most common types of chronic infection globally and displays a plethora of both gastric and extragastric effects. Among other entities, has been implicated in the pathogenesis of the metabolic syndrome. Within this review, we illustrate the current state-of-the-art evidence, which may link several components of the -related metabolic syndrome, including non-alcoholic fatty liver disease and arterial hypertension. In particular, current knowledge of how exerts its virulence through dietary, inflammatory and metabolic pathways will be discussed. Although there is still no causative link between these entities, the emerging evidence from both basic and clinical research supports the proposal that several components of the infection-related metabolic syndrome present an important risk factor in the development of arterial hypertension. The triad of infection, the metabolic syndrome, and hypertension represents a crucial worldwide health problem on a pandemic scale with high morbidity and mortality, like COVID-19, thereby requiring awareness and appropriate management on a global scale.
MeSH
Infections, Morbidity, Mortality, Hypertension, Risk Factors, Atherosclerosis, Metabolic Syndrome, Diet, Non-Alcoholic Fatty Liver Disease, Covid-19
Cited by
- Infection with may predispose to atherosclerosis: role of inflammation and thickening of intima-media of carotid arteries. Front Pharmacol, 2023
- The Role of and Metabolic Syndrome-Related Mast Cell Activation Pathologies and Their Potential Impact on Pregnancy and Neonatal Outcomes. J Clin Med, 2024
- Association of Infection and Risk of Dyslipidemia: A Systematic Review and Meta-Analysis. JGH Open, 2025
- Increased Risk to Develop Hypertension and Carotid Plaques in Patients with Long-Lasting Gastritis. J Clin Med, 2022
- Acute Infection Prevalence Among Renal Failure Patients and Its Potential Roles with Other Chronic Diseases: A Retrospective Cohort Study. Infect Drug Resist, 2022
- Searching for serum biomarkers linking coronary heart disease and Helicobacter pylori infection using infrared spectroscopy and artificial neural networks. Sci Rep, 2022
- Efficacy and safety of Jinghua Weikang capsule combined with amoxicillin-furazolidone triple/quadruple therapies in the rescue treatment of infection. Front Med (Lausanne), 2025
- Innate immunity and nonalcoholic fatty liver disease. Ann Gastroenterol, 2023
- Potential Impact of Active Infection-Related Metabolic Syndrome on Preeclampsia Among Pregnant Women [Letter]. Int J Womens Health, 2022
- Acute Helicobacter pylori infection prevalence and association with metabolic abnormality in general Chinese population: A retrospective study. Medicine (Baltimore), 2024
- A comparative study between current and past Helicobacter pylori infection in terms of microalbuminuria in patients with type 2 diabetes. BMC Infect Dis, 2024
- The relationship between circadian syndrome and its components with Helicobacter pylori infection risk: a cross-sectional study. BMC Infect Dis, 2025